Bilaketaren emaitzak - Les Brail

  • Erakusten 1 - 2 emaitzak -- 2
Findu emaitzak
  1. 1
    Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma

    Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma nork Johanna C. Bendell, Valérie André, Alan L. Ho, Ragini R. Kudchadkar, Michael R. Migden, Jeffrey R. Infante, Ramón V. Tiu, Celine Pitou, Trevor Tucker, Les Brail, Daniel D. Von Hoff

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    A Phase 1 Dose Escalation, Pharmacokinetic, and Pharmacodynamic Evaluation of eIF-4E Antisense Oligonucleotide LY2275796 in Patients with Advanced Cancer

    A Phase 1 Dose Escalation, Pharmacokinetic, and Pharmacodynamic Evaluation of eIF-4E Antisense Oligonucleotide LY2275796 in Patients with Advanced Cancer nork David S. Hong, Razelle Kurzrock, Yun Oh, Jennifer J. Wheler, Aung Naing, Les Brail, Sophie Callies, Valérie André, Sunil Kadam, Aejaz Nasir, Timothy R. Holzer, Funda Meric‐Bernstam, Mayer Fishman, George R. Simon

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: